Targeted treatment for pancreatic cancer cancer: Theranostics Nanoparticles

Posted on

Pancreatic cancer treatment presents one of the biggest challenges in clinical oncology as many patients with advanced pancreatic cancer do not respond to currently available chemotherapies and radiotherapies, and the prognosis for these patients is one of the worst among all cancer types. Multifunctional theranostic nanoparticles are developed that combines demonstrated imaging capability and receptor specificity of the nanoparticles with novel designs for tumor-targeted drug delivery. Taking advantage of surface functions and unique pharmacokinetic properties of nanoparticles, this drug delivery platform provides a potential solution for overcoming physical and intrinsic barriers that confer drug resistance in pancreatic cancer.

Explore more at


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s